Listed: Cannabis Finally Cracks America’s Major Exchanges
Cannabis stocks have, for the last five years or so, represented one of, if not the worst-performing, niche categories on any exchange.
Cannabis stocks have, for the last five years or so, represented one of, if not the worst-performing, niche categories on any exchange.
The cannabis industry is a ‘state story’: Trulieve CEO In an appearance on Yahoo Finance Live, the CEO of Florida-based MSO Trulieve Kim Rivers said that the industry will continue to grow within states — whether federal reform comes in 2022 or not.
There is more bad news from Quebec-based HEXO, who has announced that it is shuttering three production facilities — two in Ontario, one in Nova Scotia — two of which were only acquired in the last year or so.
On this episode of BofC Live, we connect with Dina Rollman, SVP of Government Affairs at Green Thumb Industries.
Sebastian St-Louis, who co-founded HEXO, is stepping down from the CEO role after a shareholder delivered a letter of complaint to the board, reports Yahoo Finance Canada.
In what they’re touting as their entry point into US cannabis when it’s federally legal, Tilray announced it has acquired a “majority position” in retailer MedMen in a creative deal that CEO Irwin Simon said could lead to a future acquisition.
Tilray, Aurora and other Canadian players say they are fixated on scooping up US cannabis assets, but Chicago-based Green Thumb Industries’ Ben Kovler is having none of it.
After securing a cool $150 million investment from Scotts Miracle-Gro subsidiary the Hawthorne Collective earlier this month, RIV Capital — formerly known as Canopy Rivers before cutting ties with Canopy Growth in February — CEO Narbe Alexandrian tells Insider what they’re planning to do with their $320 million war chest.
Tilray CEO Irwin Simon says the company is actively shopping for the right multi-state cannabis operator to forge a path into the US market.